FDA 510(k) cleared point-of-care lateral flow immunoassay for rapid detection of SARS-CoV-2 antigens. Provides results without the need for laboratory instrumentation.
Manufactured by
United States
Since 1996, InBios has been a leader in the development of diagnostic tests for emerging infectious diseases and biothreats. Products are designed for superior performance, efficiency and value. These include many FDA market authorized and CE marked assays for arboviruses, parasitic infections, biothreats, and more. InBios continues to anticipate and serve the growing global public health demand. Products in the pipeline include next generation platforms for tick-borne and respiratory diseases.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shanghai Chemtron Biotech Co.,Ltd.
China · 3 relevant products
Guangzhou Shengwei Medical Devices Co., Ltd.
China · 2 relevant products
Biopanda Reagents
United Kingdom · 1 relevant product
YASEE BioMedical Inc.
China · 1 relevant product
SHENZHEN LVSHIYUAN BIOTECHNOLOGY CO.,LTD
China · 1 relevant product
SHENZHEN MAIDE BIOTECHNOLOGY CO.,LTD
China · 1 relevant product
Anbio Biotechnology Limited
Germany · 1 relevant product
Hangzhou Frenovo Biotech Co., Ltd
China · 2 relevant products
Acon Biotech (Hangzhou) Co., Ltd.
China · 1 relevant product
Nanjing Leading Medical Technology Co. Ltd.
China · 1 relevant product
85 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →7 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 113 closest product alternatives
Shanghai Chemtron Biotech Co.,Ltd. · China
Point-of-care antigen test for rapid detection of SARS-CoV-2 in patient samples. Provides results within minutes for COVID-19 screening and diagnosis in clinical and community settings.
Guangzhou Shengwei Medical Devices Co., Ltd. · China
Point-of-care antigen test for rapid COVID-19 detection. Enables quick identification of active viral infection in clinical and non-clinical settings.
Biopanda Reagents · United Kingdom
Lateral flow immunoassay for rapid detection of SARS-CoV-2 antigen in respiratory specimens. Provides quick results for point-of-care COVID-19 diagnosis in clinical and laboratory settings.
YASEE BioMedical Inc. · China
Point-of-care rapid test for detection of SARS-CoV-2 viral antigens. Supports clinical diagnosis and mass screening during pandemic response.
Shanghai Chemtron Biotech Co.,Ltd. · China
A rapid diagnostic test for the detection of COVID-19 antigens. This point-of-care test provides quick identification of active SARS-CoV-2 infection.
SHENZHEN LVSHIYUAN BIOTECHNOLOGY CO.,LTD · China
Point-of-care (POCT) antigen detection test for SARS-CoV-2. Provides rapid qualitative results for COVID-19 diagnosis. Included on manufacturer whitelist for approved diagnostic suppliers.
SHENZHEN MAIDE BIOTECHNOLOGY CO.,LTD · China
Point-of-care rapid antigen test for SARS-CoV-2 detection with results available within 15-20 minutes. Designed for clinical use in hospitals, clinics, and testing centers with high sensitivity and specificity.
Anbio Biotechnology Limited · Germany
Point-of-care immunoassay for rapid detection of COVID-19 antigens in clinical samples. Delivers results within 15-30 minutes for immediate clinical decision-making.
Hangzhou Frenovo Biotech Co., Ltd · China
Rapid diagnostic test for detection of SARS-CoV-2 antigen. Provides quick identification of active COVID-19 infection for point-of-care testing.
Acon Biotech (Hangzhou) Co., Ltd. · China
Rapid diagnostic test for SARS-CoV-2 detection. Provides point-of-care testing capability for COVID-19 screening and confirmation.
Nanjing Leading Medical Technology Co. Ltd. · China
Rapid antigen detection test for identifying current SARS-CoV-2 infection. Designed for point-of-care testing applications in clinical and screening settings.
AssureTech.(Hangzhou) Co.,Ltd. · China
Rapid antigen detection device for COVID-19 diagnosis at point-of-care settings. Delivers qualitative results to identify active SARS-CoV-2 infection from respiratory samples. Designed for clinical and screening applications requiring quick turnaround times.
101 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products